UA118076C2 - MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION - Google Patents

MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION

Info

Publication number
UA118076C2
UA118076C2 UAA201803422A UAA201803422A UA118076C2 UA 118076 C2 UA118076 C2 UA 118076C2 UA A201803422 A UAA201803422 A UA A201803422A UA A201803422 A UAA201803422 A UA A201803422A UA 118076 C2 UA118076 C2 UA 118076C2
Authority
UA
Ukraine
Prior art keywords
concentrate
preparation
infusion solution
medicinal product
bioflavonoid
Prior art date
Application number
UAA201803422A
Other languages
Ukrainian (uk)
Inventor
Сергій Вікторович Бобокало
Людмила Григорівна Алмакаєва
Владімір Міхайловіч Старовєров
Original Assignee
Сергій Вікторович Бобокало
Людмила Григорівна Алмакаєва
Владімір Міхайловіч Старовєров
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сергій Вікторович Бобокало, Людмила Григорівна Алмакаєва, Владімір Міхайловіч Старовєров filed Critical Сергій Вікторович Бобокало
Publication of UA118076C2 publication Critical patent/UA118076C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Лікарський засіб у формі концентрату для приготування інфузійного розчину містить діючу речовину на основі біофлавоноїду, допоміжні речовини та воду для ін'єкцій, як біофлавоноїд містить дигідрокверцетин, додатково містить трометамол, а як допоміжні речовини містить полівінілпіролідон з м. м. 8000 або поліетиленоксид 400, або пропіленгліколь 1,2, або їх комбінації.The drug in the form of concentrate for the preparation of infusion solution contains the active substance based on bioflavonoid, excipients and water for injection, as the bioflavonoid contains dihydroquercetin, additionally contains trometamol, and as excipients contains polyvinylpyrrolidone with m. or propylene glycol 1,2, or combinations thereof.

UAA201803422A 2016-07-01 2016-07-01 MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION UA118076C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201607155A UA117389C2 (en) 2016-07-01 2016-07-01 MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION

Publications (1)

Publication Number Publication Date
UA118076C2 true UA118076C2 (en) 2018-11-12

Family

ID=63041298

Family Applications (3)

Application Number Title Priority Date Filing Date
UAA201803421A UA118075C2 (en) 2016-07-01 2016-07-01 MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION
UAA201803422A UA118076C2 (en) 2016-07-01 2016-07-01 MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION
UAA201607155A UA117389C2 (en) 2016-07-01 2016-07-01 MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA201803421A UA118075C2 (en) 2016-07-01 2016-07-01 MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA201607155A UA117389C2 (en) 2016-07-01 2016-07-01 MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION

Country Status (1)

Country Link
UA (3) UA118075C2 (en)

Also Published As

Publication number Publication date
UA117389C2 (en) 2018-07-25
UA118075C2 (en) 2018-11-12

Similar Documents

Publication Publication Date Title
MX2021006035A (en) Stable cannabinoid formulations.
CA3030422C (en) Stabilizing excipients for therapeutic protein formulations
EA201591701A1 (en) COMBINATION OF ANTI-VIRAL DIRECT ACTION AND RIBAVIRIN FOR THE TREATMENT OF PATIENTS WITH HCV
BR112018015367A2 (en) nanofiber oromucosal carriers for therapeutic treatment
CY1123366T1 (en) 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
CY1119532T1 (en) (S) -PYRILDOL AND THE PHARMACEUTALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
BR112015023481A2 (en) controlled release liposome drug composition
MX2016015211A (en) Topical formulations and uses thereof.
ECSP18060820A (en) DERIVATIVES OF 3- (CARBOXYETHYL) -8-AMINO-2-OXO-1,3-DIAZA-SPIRO- [4.5] - DECANE
CY1119522T1 (en) (R) - PILINDOL AND THE PHARMACEUTICALALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
CL2016000543A1 (en) Use of pidotimod or its stereoisomers and / or physiologically acceptable salts to prepare a medicament useful in the treatment of diseases associated with inflammation, where there is aberrant hyperactivation of the non-canonical nfkb pathway.
UA118076C2 (en) MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION
MX2018008196A (en) Treatment of breast cancer using a combination of a cationic liposomal formulation of taxane, a non-liposomal formulation of taxane and a further active agent.
FR3026012B1 (en) ORAL ADMINISTRATION OF AT LEAST ONE PHARMACEUTICAL AND / OR ANTIGENIC ACTIVE SUBSTANCE
UA122333U (en) THE COMPOSITION OF ANTI-Fungal, Antimicrobial and Keratolytic Drug
UA123395U (en) PHARMACEUTICAL COMPOSITION OF NISTATIN IN THE FORM OF ORAL SUSPENSION
UA131944U (en) DRUG FOR PREVENTION AND TREATMENT OF PROSTATITIS
UA106472U (en) Composition for treating dermatological diseases
UA115903U (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF GEL FOR TREATMENT OF ALLERGIC DISEASES OF THE SKIN
WO2016115442A3 (en) Therapeutic protein formulations
UA106471U (en) Composition for treating dermatological diseases
MX2017014471A (en) Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy.
UA112611U (en) METHOD OF INSECTOACARICIDIC TREATMENT OF BIRDS AND POULTRY OBJECTS
EA201692163A1 (en) MEDICINE FOR THE TREATMENT OF PATIENTS WITH TINNITUS
UA114828C2 (en) APPLICATION OF DECAMETOXIN AS A PHARMACEUTICAL ACTIVE SUBSTANCE FOR TREATMENT OF Gastrointestinal and Intestinal Infections Oral